Moderna, Inc.
MRNA
$101.41
-$0.59-0.58%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 2.79B | 1.76B | 293.00M | 1.83B | 4.86B |
| Total Other Revenue | 18.00M | 74.00M | 51.00M | 34.00M | 225.00M |
| Total Revenue | 2.81B | 1.83B | 344.00M | 1.86B | 5.08B |
| Cost of Revenue | 2.34B | 3.40B | 1.88B | 1.92B | 3.13B |
| Gross Profit | 476.00M | -1.57B | -1.54B | -61.00M | 1.96B |
| SG&A Expenses | 470.00M | 442.00M | 332.00M | 305.00M | 375.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.81B | 3.84B | 2.21B | 2.23B | 3.50B |
| Operating Income | 6.00M | -2.01B | -1.87B | -366.00M | 1.58B |
| Income Before Tax | 70.00M | -1.96B | -1.75B | -305.00M | 1.66B |
| Income Tax Expenses | -147.00M | 1.67B | -369.00M | -384.00M | 190.00M |
| Earnings from Continuing Operations | 217.00M | -3.63B | -1.38B | 79.00M | 1.47B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 217.00M | -3.63B | -1.38B | 79.00M | 1.47B |
| EBIT | 6.00M | -2.01B | -1.87B | -366.00M | 1.58B |
| EBITDA | 208.00M | -1.76B | -1.78B | -288.00M | 1.66B |
| EPS Basic | 0.57 | -9.53 | -3.62 | 0.20 | 3.81 |
| Normalized Basic EPS | 0.15 | -3.15 | -2.91 | -0.44 | 2.69 |
| EPS Diluted | 0.54 | -9.53 | -3.62 | 0.19 | 3.64 |
| Normalized Diluted EPS | 0.15 | -3.15 | -2.91 | -0.42 | 2.56 |
| Average Basic Shares Outstanding | 381.00M | 381.00M | 381.00M | 386.00M | 385.00M |
| Average Diluted Shares Outstanding | 395.00M | 381.00M | 381.00M | 405.00M | 405.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
